Search Results

ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer

by D. Planchard, N. Reinmuth, S. Orlov, J. R. Fischer, S. Sugawara, S. Mandziuk, D. Marquez-Medina, S. Novello, Y. Takeda, R. Soo, K. Park, M. McCleod, S. L. Geater, M. Powell, R. May, U. Scheuring, P. Stockman, D. Kowalski
Published in Annals of Oncology (2020)